Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04482309
Title A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

ovary epithelial cancer

endometrial cancer

pancreatic cancer

urinary bladder cancer

biliary tract cancer

cervical cancer

Advanced Solid Tumor

Therapies

Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | BEL


No variant requirements are available.